Market Access/ News/ News FDA approves Janssen’s ketamine-based nasal antidepressant George Underwood depression, esketamine, fda, Jansse, ketamine, Spravato 0 Comment The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment Share X FDA approves Janssen’s ketamine-based nasal antidepressant https://pharmaphorum.com/news/fda-approves-janssens-ketamine-based-nasal-antidepressant/
depression, esketamine, fda, Jansse, ketamine, Spravato
0 Comment
